CIK 0001357459
- Non-accelerated filer
- Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522007292
- Phone
- +1 858-704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-24 | LLOYD JONES JONATHAN BRIAN Chief Financial Officer | Purchase | +5,455 | $5.50 | $30K | 7,859 |
| 2017-02-24 | Daly Richard J Chief Executive Officer | Purchase | +2,591 | $3.86 | $10K | 15,812 |
| 2017-01-25 | Daly Richard J Chief Executive Officer | Purchase | +2,841 | $3.52 | $10K | 13,221 |
| 2016-12-23 | Daly Richard J Chief Executive Officer | Purchase | +32,259 | $0.31 | $10K | 134,939 |
| 2016-11-25 | Daly Richard J Chief Executive Officer | Purchase | +35,715 | $0.28 | $10K | 102,680 |
| 2016-10-25 | Daly Richard J Chief Executive Officer | Purchase | +35,715 | $0.28 | $10K | 66,965 |
| 2016-09-23 | LLOYD JONES JONATHAN BRIAN Chief Financial Officer | Purchase | +31,250 | $0.32 | $10K | 31,250 |
| 2016-09-23 | Daly Richard J Chief Executive Officer | Purchase | +31,250 | $0.32 | $10K | 31,250 |
| 2016-03-08 | LLOYD JONES JONATHAN BRIAN Chief Financial Officer | Grant or award · Common Stock Purchase Option | +79,776 | 79,776 | ||
| 2016-01-27 | GARR RICHARD CEO | Option exercise | +19,802 | 1,456,269 | ||
| 2016-01-27 | GARR RICHARD CEO | Shares withheld for taxes | −6,465 | $0.67 | $4K | 1,449,804 |
| 2016-01-27 | GARR RICHARD CEO | Option exercise · Restricted Stock Unit | −19,802 | 0 | ||
| 2015-11-19 | OLDAKER WILLIAM CLYDE Director | Option exercise | +15,000 | 196,826 | ||
| 2015-11-19 | OLDAKER WILLIAM CLYDE Director | Option exercise · Restricted Stock Unit | −15,000 | 0 | ||
| 2015-11-19 | GARR RICHARD CEO | Option exercise | +138,122 | 1,474,243 | ||
| 2015-11-19 | GARR RICHARD CEO | Shares withheld for taxes | −37,776 | $1.14 | $43K | 1,436,467 |
| 2015-11-19 | GARR RICHARD CEO | Option exercise · Restricted Stock Unit | −138,122 | 0 | ||
| 2015-11-19 | JOHE KARL Chief Scientific Officer | Option exercise | +143,247 | 969,551 | ||
| 2015-11-19 | JOHE KARL Chief Scientific Officer | Shares withheld for taxes | −39,178 | $1.14 | $45K | 930,373 |
| 2015-11-19 | JOHE KARL Chief Scientific Officer | Option exercise · Restricted Stock Unit | −143,247 | 0 |
Page 18 of 21 · 409 trades